Status: Recruiting
Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels
The aim of this clinical trial is to analyze the negative predictive capacity and safety of risk-stratified direct drug provocation tests for patients with self-reported penicillin allergies. Patients reporting immediate or delayed penicillin allergies and defined as low-risk by the PEN-FAST score will receive drug provocation tests without prior skin testing.
Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Deniz GöcebeUpdated: Apr 10, 2025Locations: 2
Eligibility criteria
Adult outpatients or inpatients with a penicillin allergy label [+2]
Age <18 years [+9]